← Leaderboards
Rocky Lee Baker
University Of Colorado Denver
$2,368,600
Attributed
$2,368,600
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $388.8K · FY2018–24$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,368,600 · 2
By mechanism
R01$1,940,975 · 1
R21$427,625 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- V Michael Holers$38,234,826
- George S Eisenbarth$13,354,570
- Roberta Pelanda$15,844,961
- Kathryn Haskins$12,584,495
- Aaron W Michels$8,254,447
Others in their field
Other Emerging Leaders on “Insulin Dependent Diabetes Mellitus Onset”
- Barbara Halina Braffett · George Washington University$7,285,878
- Michelle Meyer · Univ Of North Carolina Chapel Hill$5,388,957
- Adam R Konopka · University Of Wisconsin-Madison$4,344,776
- Esther Marian Blessing · New York University School Of Medicine$4,104,231
- Ionut Bebu · George Washington University$4,085,753
- Katherine W. Bauer · University Of Michigan At Ann Arbor$3,987,963
Research focus
Insulin Dependent Diabetes Mellitus OnsetIsletInbred Nod MiceInsulin-Dependent Diabetes MellitusAutoimmune DiseasesInvestigationHuman DiseaseImmunologyInsulinEnzyme Linked Immunospot AssayBeta CellBiological MarkersCd4 Positive T LymphocytesCellsChromogranin AAutoantigensAutoimmunityHybridsAutoreactive T CellInflammatoryAutoimmune DiabetesEffector T CellDiabetes MellitusIslet Amyloid Polypeptide
Grant awards (7)
Responses to Hybrid Insulin Peptides as Biomarkers of Disease Activity in Human Type 1 Diabetes$388,750
R01 · FY2024 · AI · contact PI
Responses to Hybrid Insulin Peptides as Biomarkers of Disease Activity in Human Type 1 Diabetes$388,750
R01 · FY2023 · AI · contact PI
Responses to Hybrid Insulin Peptides as Biomarkers of Disease Activity in Human Type 1 Diabetes$388,750
R01 · FY2022 · AI · contact PI
Responses to Hybrid Insulin Peptides as Biomarkers of Disease Activity in Human Type 1 Diabetes$388,750
R01 · FY2021 · AI · contact PI
Responses to Hybrid Insulin Peptides as Biomarkers of Disease Activity in Human Type 1 Diabetes$385,975
R01 · FY2020 · AI · contact PI
T cells reactive to Hybrid Insulin Peptides (HIPs) as biomarkers in autoimmune diabetes$233,250
R21 · FY2019 · AI · contact PI
T cells reactive to Hybrid Insulin Peptides (HIPs) as biomarkers in autoimmune diabetes$194,375
R21 · FY2018 · AI · contact PI